Associations of Carotid Plaque Characteristics With Brain Perfusion and Cognitive Function in Patients Undergoing CEA
1 other identifier
observational
100
1 country
1
Brief Summary
Stroke is one of the leading causes of death and disability-adjusted life-years worldwide. Carotid high-risk atherosclerotic plaques are considered to be one of the major sources of ischemic stroke. The present study aimed to investigate the relationship of carotid plaque characteristics with brain perfusion and cognitive function in patients undergoing carotid endarterectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedFirst Submitted
Initial submission to the registry
June 29, 2021
CompletedFirst Posted
Study publicly available on registry
July 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedJuly 8, 2021
June 1, 2021
1.9 years
June 29, 2021
June 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
brain perfusion
perioperative brain perfusion and changes of brain perfusion in patients underging CEA
From preoperative to 24 months after operation (CEA)
cognitive function
perioperative cognitive function and cognitive changes in patients underging CEA
From preoperative to 24 months after operation (CEA)
Study Arms (1)
patients
patients with caotid atherosclerosis refering to carotid endarterectomy
Interventions
Eligibility Criteria
Patients with carotid atherosclerosis refering to CEA in our hospital
You may qualify if:
- Over 30 years old;
- The patients with symptomatic (\>50%) or asymptomatic carotid stenosis (\> 70%) measured by computed tomography angiography (CTA) or B-mode ultrasonography
- CEA operation will be performed in our hospital.
You may not qualify if:
- The history of CEA operation in the last 3 months;
- Diseases (AF, valve diseases, etc.) that may cause cardiac thrombosis;
- Contraindications of MR examination (vascular stent implantation, pacemaker, metal or magnetic plants in vivo, claustrophobia, etc.) were found;
- Contraindications of contrast agents: such as renal failure, iodine or gadolinium contrast agent allergy;
- Having heart or respiratory failure;
- Serious consciousness disorder (coma, etc.);
- Brain tumor;
- Acute cerebral hemorrhage;
- Pregnant women or planned pregnancies in the past 2 years;
- Who does not agree to sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Third Hospital
Beijing, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Huishu Yuan, Dr.
Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2021
First Posted
July 8, 2021
Study Start
September 1, 2019
Primary Completion
July 31, 2021
Study Completion
July 31, 2023
Last Updated
July 8, 2021
Record last verified: 2021-06